Nebenwirkungen · Victoza
Victoza 6 mg/ml solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 8
HOS-121376 · Präparat HOS-095335
Paediatric population Overall, frequency, type and severity of adverse reactions in adolescents and children aged 10 years and above were comparable to that observed in the adult population. Rate of confirmed hypoglycaemic episodes was higher with liraglutide (0.58 events/patient year) compared to placebo (0.29 events/patient year). In patients treated with insulin prior to a confirmed hypoglycaemic episode the rate was higher with liraglutide (1.82 events/patient year) compared to placebo (0.91 events/patient years). No severe hypoglycaemic episodes occurred in the liraglutide treatment group.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T09:40:00Z · SHA-256 3a502ddc6b1f34762776a7b9d1d0598e240a894a70f095fa9d0346bd835291c7 · Passage 899514242e36e077f2ac00bf21fbd24f0d277085d1d980cd5d5f7dfe8d235e19 · Zeichen 8996–9597 im Abschnitt